{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:15:36Z","timestamp":1794809736183,"version":"4.9.1"},"reference-count":75,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck KGaA, Darmstadt, Germany","award":["ID: 10.13039\/100009945"],"award-info":[{"award-number":["ID: 10.13039\/100009945"]}],"id":[{"id":"https:\/\/ror.org\/04b2dty93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Leibniz Institute for Immunotherapy Regensburg","award":["N.A."],"award-info":[{"award-number":["N.A."]}],"id":[{"id":"https:\/\/ror.org\/00xn1pr13","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Else Kr\u00f6ner-Fresenius-Foundation","award":["N.A."],"award-info":[{"award-number":["N.A."]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background &amp; Aims<\/jats:title>\n                    <jats:p>Intratumoral lactate accumulation and acidosis impair T-cell function and antitumor immunity. Interestingly, expression of the lactate transporter monocarboxylate transporter (MCT) 4, but not MCT1, turned out to be prognostic for the survival of patients with rectal cancer, indicating that single MCT4 blockade might be a promising strategy to overcome glycolysis-related therapy resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To determine whether blockade of MCT4 alone is sufficient to improve the efficacy of immune checkpoint blockade (ICB) therapy, we examined the effects of the selective MCT1 inhibitor AZD3965 and a novel MCT4 inhibitor in a colorectal carcinoma (CRC) tumor spheroid model co-cultured with blood leukocytes in vitro and the MC38 murine CRC model in vivo in combination with an antibody against programmed cell death ligand-1(PD-L1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inhibition of MCT4 was sufficient to reduce lactate efflux in three-dimensional (3D) CRC spheroids but not in two-dimensional cell-cultures. Co-administration of the MCT4 inhibitor and ICB augmented immune cell infiltration, T-cell function and decreased CRC spheroid viability in a 3D co-culture model of human CRC spheroids with blood leukocytes. Accordingly, combination of MCT4 and ICB increased intratumoral pH, improved leukocyte infiltration and T-cell activation, delayed tumor growth, and prolonged survival in vivo. MCT1 inhibition exerted no further beneficial impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings demonstrate that single MCT4 inhibition represents a novel therapeutic approach to reverse lactic-acid driven immunosuppression and might be suitable to improve ICB efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2023-007349","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T21:25:29Z","timestamp":1698269129000},"page":"e007349","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":148,"title":["MCT4 blockade increases the efficacy of immune checkpoint blockade"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct01791595","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-322X","authenticated-orcid":false,"given":"Nathalie","family":"Babl","sequence":"first","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja-Maria","family":"Decking","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"},{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"},{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Voll","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"},{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Althammer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Sala-Hojman","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ferretti","sequence":"additional","affiliation":[{"name":"EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa","family":"Korf","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schmidl","sequence":"additional","affiliation":[{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schmidleithner","sequence":"additional","affiliation":[{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Nerb","sequence":"additional","affiliation":[{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Matos","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun E","family":"Koehl","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-6213","authenticated-orcid":false,"given":"Peter","family":"Siska","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Bruss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"},{"name":"Department of Gynecology and Obstetrics, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Kellermeier","sequence":"additional","affiliation":[{"name":"Institute of Functional Genomics, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Dettmer","sequence":"additional","affiliation":[{"name":"Institute of Functional Genomics, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Oefner","sequence":"additional","affiliation":[{"name":"Institute of Functional Genomics, University of Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Wichland","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Ugele","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bohr","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Herr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivapriya","family":"Ramaswamy","sequence":"additional","affiliation":[{"name":"EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Heinrich","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Herhaus","sequence":"additional","affiliation":[{"name":"Merck Healthcare KGaA, Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kreutz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"},{"name":"Leibniz Institute for Immunotherapy, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Renner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany"},{"name":"Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"key":"2025100313381109000_11.10.e007349.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"2025100313381109000_11.10.e007349.2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/imr.12846","article-title":"The immunological Warburg effect: can a metabolic-tumor-Stroma score (Mets) guide cancer Immunotherapy","volume":"295","author":"Siska","year":"2020","journal-title":"Immunol Rev"},{"key":"2025100313381109000_11.10.e007349.3","first-page":"916","article-title":"High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human Cervical cancers","volume":"60","author":"Walenta","year":"2000","journal-title":"Cancer Res"},{"key":"2025100313381109000_11.10.e007349.4","doi-asserted-by":"publisher","DOI":"10.1007\/s10863-012-9428-1"},{"key":"2025100313381109000_11.10.e007349.5","doi-asserted-by":"crossref","unstructured":"Choi J-W , Kim Y , Lee J-H , et al . Prognostic significance of lactate\/proton Symporters Mct1, Mct4, and their chaperone Cd147 expressions in urothelial carcinoma of the bladder. Urology 2014;84. doi:10.1016\/j.urology.2014.03.031","DOI":"10.1016\/j.urology.2014.03.031"},{"key":"2025100313381109000_11.10.e007349.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.06.010"},{"key":"2025100313381109000_11.10.e007349.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490"},{"key":"2025100313381109000_11.10.e007349.8","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26410"},{"key":"2025100313381109000_11.10.e007349.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.08.011"},{"key":"2025100313381109000_11.10.e007349.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.12.018"},{"key":"2025100313381109000_11.10.e007349.11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"2025100313381109000_11.10.e007349.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.02.024"},{"key":"2025100313381109000_11.10.e007349.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.08.068"},{"key":"2025100313381109000_11.10.e007349.14","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.201900544"},{"key":"2025100313381109000_11.10.e007349.15","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.13.151","article-title":"Small-molecule inhibitors of human Ldh5","volume":"5","author":"Granchi","year":"2013","journal-title":"Future Med Chem"},{"key":"2025100313381109000_11.10.e007349.16","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio744"},{"key":"2025100313381109000_11.10.e007349.17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.32348","article-title":"Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma Immunotherapy through enhancing T cell infiltration and immune attack","volume":"77","author":"Fang","year":"2023","journal-title":"Hepatology"},{"key":"2025100313381109000_11.10.e007349.18","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/242437","article-title":"Prognostic indications of elevated Mct4 and Cd147 across cancer types: A meta-analysis","volume":"2015","author":"Bovenzi","year":"2015","journal-title":"Biomed Res Int"},{"key":"2025100313381109000_11.10.e007349.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.11.025"},{"key":"2025100313381109000_11.10.e007349.20","doi-asserted-by":"publisher","DOI":"10.1002\/path.4562"},{"key":"2025100313381109000_11.10.e007349.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0558-5"},{"key":"2025100313381109000_11.10.e007349.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-016-2566-9","article-title":"Significance of Glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis","volume":"16","author":"Martins","year":"2016","journal-title":"BMC Cancer"},{"key":"2025100313381109000_11.10.e007349.23","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"2025100313381109000_11.10.e007349.24","doi-asserted-by":"crossref","DOI":"10.4081\/oncol.2019.403","article-title":"Mct4 has a potential to be used as a Prognostic biomarker - a systematic review and meta-analysis","volume":"13","author":"Javaeed","year":"2019","journal-title":"Oncol Rev"},{"key":"2025100313381109000_11.10.e007349.25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cjp2.250","article-title":"Expression of proteins associated with the Warburg-effect and survival in colorectal cancer","volume":"8","author":"Offermans","year":"2022","journal-title":"J Pathol Clin Res"},{"key":"2025100313381109000_11.10.e007349.26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/etm.2011.361","article-title":"Prognostic significance of Monocarboxylate transporter 4 expression in patients with colorectal cancer","volume":"3","author":"Nakayama","year":"2012","journal-title":"Exp Ther Med"},{"key":"2025100313381109000_11.10.e007349.27","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02229-6","article-title":"ROS\/Pi3K\/AKT and WNT\/\u0392-Catenin Signalings activate HIF-1\u0391-induced metabolic Reprogramming to impart 5-fluorouracil resistance in colorectal cancer","volume":"41","author":"Dong","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"2025100313381109000_11.10.e007349.28","doi-asserted-by":"publisher","DOI":"10.1021\/pr3010106"},{"key":"2025100313381109000_11.10.e007349.29","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/SLA.0b013e31829d5c45","article-title":"Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies","volume":"259","author":"Mirnezami","year":"2014","journal-title":"Ann Surg"},{"key":"2025100313381109000_11.10.e007349.30","doi-asserted-by":"crossref","DOI":"10.1186\/s40246-022-00377-0","article-title":"A Glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with Rectal cancer","volume":"16","author":"Liu","year":"2022","journal-title":"Hum Genomics"},{"key":"2025100313381109000_11.10.e007349.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.02.025"},{"key":"2025100313381109000_11.10.e007349.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129139"},{"key":"2025100313381109000_11.10.e007349.33","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2830"},{"key":"2025100313381109000_11.10.e007349.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1851"},{"key":"2025100313381109000_11.10.e007349.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0126-x"},{"key":"2025100313381109000_11.10.e007349.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65436-3"},{"key":"2025100313381109000_11.10.e007349.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.03.030"},{"key":"2025100313381109000_11.10.e007349.38","doi-asserted-by":"crossref","first-page":"11904","DOI":"10.1021\/acs.jmedchem.1c00448","article-title":"Discovery of 5-{2-5-Chloro-2-(5-Ethoxyquinoline-8-Sulfonamido)Phenylethynyl}-4-Methoxypyridine-2-Carboxylic acid, a highly selective in vivo useable chemical probe to dissect Mct4 biology","volume":"64","author":"Heinrich","year":"2021","journal-title":"J Med Chem"},{"key":"2025100313381109000_11.10.e007349.39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-2270"},{"key":"2025100313381109000_11.10.e007349.40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2034"},{"key":"2025100313381109000_11.10.e007349.41","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2260"},{"key":"2025100313381109000_11.10.e007349.42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1021\/acs.jmedchem.2c01342","article-title":"Discovery of clinical candidate Azd0095, a selective inhibitor of Monocarboxylate transporter 4 (Mct4) for oncology","volume":"66","author":"Goldberg","year":"2023","journal-title":"J Med Chem"},{"key":"2025100313381109000_11.10.e007349.43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007053","article-title":"Metabolic Reprogramming Dynamics in tumor Spheroids: insights from a Multicellular, Multiscale model","volume":"15","author":"Roy","year":"2019","journal-title":"PLoS Comput Biol"},{"key":"2025100313381109000_11.10.e007349.44","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-022-00285-w","article-title":"Metabolic flux analysis of 3d Spheroids reveals significant differences in glucose metabolism from matched 2d cultures of colorectal cancer and Pancreatic Ductal adenocarcinoma cell lines","volume":"10","author":"Tidwell","year":"2022","journal-title":"Cancer Metab"},{"key":"2025100313381109000_11.10.e007349.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.05.004"},{"key":"2025100313381109000_11.10.e007349.46","doi-asserted-by":"crossref","unstructured":"Selby MJ , Engelhardt JJ , Johnston RJ , et al . Preclinical development of Ipilimumab and Nivolumab combination Immunotherapy: Mouse tumor models. PLOS ONE 2016. doi:10.1371\/journal.pone.0161779","DOI":"10.1371\/journal.pone.0161779"},{"key":"2025100313381109000_11.10.e007349.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01211-7"},{"key":"2025100313381109000_11.10.e007349.48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and Immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"2025100313381109000_11.10.e007349.49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly Glycolytic tumor Microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"2025100313381109000_11.10.e007349.50","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040450","article-title":"Blockade of lactate dehydrogenase-A (LDH-A) improves efficacy of anti-programmed cell Death-1 (PD-1) therapy in Melanoma","volume":"11","author":"Daneshmandi","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2025100313381109000_11.10.e007349.51","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0072"},{"key":"2025100313381109000_11.10.e007349.52","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.18632\/oncotarget.26760","article-title":"Novel N,N-Dialkyl Cyanocinnamic acids as Monocarboxylate transporter 1 and 4 inhibitors","volume":"10","author":"Jonnalagadda","year":"2019","journal-title":"Oncotarget"},{"key":"2025100313381109000_11.10.e007349.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.11.043"},{"key":"2025100313381109000_11.10.e007349.54","doi-asserted-by":"crossref","first-page":"112393","DOI":"10.1016\/j.ejmech.2020.112393","article-title":"Monocarboxylate transporter 1 and 4 inhibitors as potential Therapeutics for treating solid tumours: A review with structure-activity relationship insights","volume":"199","author":"Puri","year":"2020","journal-title":"Eur J Med Chem"},{"key":"2025100313381109000_11.10.e007349.55","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-1253"},{"key":"2025100313381109000_11.10.e007349.56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2263"},{"key":"2025100313381109000_11.10.e007349.57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511397200"},{"key":"2025100313381109000_11.10.e007349.58","unstructured":"Critchlow SE . New Developments in Targeting Lactate Transporters. AACR: Chicago, 2018."},{"key":"2025100313381109000_11.10.e007349.59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","article-title":"The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure","volume":"33","author":"Cluntun","year":"2021","journal-title":"Cell Metab"},{"key":"2025100313381109000_11.10.e007349.60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb8969","article-title":"Metabolic Reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans","volume":"12","author":"Uhl","year":"2020","journal-title":"Sci Transl Med"},{"key":"2025100313381109000_11.10.e007349.61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour Microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature"},{"key":"2025100313381109000_11.10.e007349.62","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019"},{"key":"2025100313381109000_11.10.e007349.63","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2938"},{"key":"2025100313381109000_11.10.e007349.64","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.603589"},{"key":"2025100313381109000_11.10.e007349.65","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-3121"},{"key":"2025100313381109000_11.10.e007349.66","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic Microenvironment of Melanomas: Prognostic value of Mct1 and Mct4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle"},{"key":"2025100313381109000_11.10.e007349.67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijso.2016.10.001","article-title":"Monocarboxylate transporter 4 as a Prognostic biomarker in patients with colorectal cancer and liver metastases","volume":"5","author":"Petrides","year":"2016","journal-title":"International Journal of Surgery Open"},{"key":"2025100313381109000_11.10.e007349.68","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/ajco.13077","article-title":"The Prognostic significance of the expression of Monocarboxylate transporter 4 in patients with Right- or left-sided colorectal cancer","volume":"15","author":"Abe","year":"2019","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025100313381109000_11.10.e007349.69","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.5037"},{"key":"2025100313381109000_11.10.e007349.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2010.03.031"},{"key":"2025100313381109000_11.10.e007349.71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jso.23998","article-title":"Tumor-infiltrating Cd8(+) T lymphocytes associated with clinical outcome in Anal squamous cell carcinoma","volume":"112","author":"Hu","year":"2015","journal-title":"J Surg Oncol"},{"key":"2025100313381109000_11.10.e007349.72","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3181b6a741"},{"key":"2025100313381109000_11.10.e007349.73","first-page":"7450","article-title":"Adoptive transfer of tumor cytotoxic Macrophages generated in vitro from circulating blood monocytes: a new approach to cancer Immunotherapy","volume":"50","author":"Andreesen","year":"1990","journal-title":"Cancer Res"},{"key":"2025100313381109000_11.10.e007349.74","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00327.2002"},{"key":"2025100313381109000_11.10.e007349.75","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0546-8"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2023-007349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:38:24Z","timestamp":1759523904000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2023-007349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":75,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,25]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/jitc-2023-007349"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2023-007349","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}